Sanofi SA (LTS:0A2V)
$ 49 0 (0%) Market Cap: 122.85 Bil Enterprise Value: 141.18 Bil PE Ratio: 28.19 PB Ratio: 1.63 GF Score: 87/100

Sanofi SA at Jefferies Healthcare Conference Transcript

Jun 09, 2022 / 06:30PM GMT
Release Date Price: $52.38 (-1.21%)
Peter James Welford
Jefferies LLC, Research Division - Senior Equity Analyst & European Pharmaceuticals Analyst

Okay. Thank you all. We'll get started. My name is Peter Welford. I'm the European pharma and biotech analyst at Jefferies in London. It's my great pleasure to introduce the next company, which is obviously Sanofi. And here today, we have John Reed, who is the Head of R&D.

It's a fireside chat. If anyone in the audience does have any questions, by all means, raise your hand. And I think we've got a mic out there; we can try and get to you. Apologies, we can't actually see you very much, so you might jump up and down as well.

But with that, we'll get started. So right John, let's start off.

John C. Reed
Sanofi - Executive VP and Global Head of Research & Development

Can I first say that given how cold it is in here, I wish we did have a fire? This is amazing, yes. But anyway, okay.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot